GLAXOSMITHKLINE PHARMACEUTICALS LTD.

GLAXOSMITHKLINE PHARMACEUTICALS LTD. - Change in Directorate

	< Back
06 Nov 2014
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE as under:<br/><br/>1. The Board of Directors at its Meeting held on November 06, 2014 has appointed Mr. Andrew Aristidou as the Chief Financial Officer and Executive Director of the Company from December 01, 2014.<br/><br/>2. Mr. Mehernosh Kapadia, current Chief Financial Officer and Senior Executive Director will retire from service on November 30, 2014 and will cease to be a Director of the Company from December 01, 2014.<br/><br/>The Board of Directors of the Company have placed on record its warm appreciation of the valuable services rendered by Mr. Mehernosh Kapadia as Director of the Company for over 18 years.
View all announcements for GLAXOSMITHKLINE PHARMACEUTICALS LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us